The prospective cohort study investigating the relationship between circulating CD271-positive mononuclear cells in acute coronary syndrome and secondary coronary events

The prospective cohort study investigating the relationship between circulating CD271-positive mononuclear cells in acute coronary syndrome and secondary coronary events - ACS-CD271 study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026512

Enrollment

100

Registered

2017-04-01

Start date

2016-05-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed with acute coronary syndrome and emergent coronary angiography and percutaneous coronary intervention are considered to be performed.

Exclusion criteria

Exclusion criteria: Patients on any following conditions; - Cardiogenic shock - Instability of vital signs requiring a mechanical circulatory or respiratory support - Deteriorating brady or tachy-arrhythmia - Hemodialysis - Allergy for iodine or anti-thrombotic drugs - Malignancy - Active infectious diseases

Design outcomes

Primary

Measure	Time frame
-Progression of coronary plaque in a non-targeted lesion at between 9 and 12 months follow-up(: including total plaque capacity, plaque volume of lipid core, plaque volume of calcification, minimal thickness of fibrous cap and CT values)	—

Secondary

Measure	Time frame
-Progression of coronary plaque in a targeted lesion after primary revascularization at between 9 and 12 months follow-up -Revascularization at the restenotic lesion -Coronary intervention for de-novo lesion -Major cerebral and cardiovascular events (: cardiovascular death, non-fetal myocardial infarction, unstable angina, unexpected coronary vascularization, stroke and admission due to decompensated heart failure )	—

Measure

Time frame

-Progression of coronary plaque in a targeted lesion after primary revascularization at between 9 and 12 months follow-up -Revascularization at the restenotic lesion -Coronary intervention for de-novo lesion -Major cerebral and cardiovascular events (: cardiovascular death, non-fetal myocardial infarction, unstable angina, unexpected coronary vascularization, stroke and admission due to decompensated heart failure )

—

Countries

Japan

Contacts

Public ContactSayaka Kinoshita

Kanazawa University Innovative Clinical Research Center

hpsangak@adm.kanazawa-u.ac.jp076-265-2072

Outcome results